ProShare Advisors LLC Buys 75,514 Shares of The Clorox Company $CLX

ProShare Advisors LLC increased its stake in The Clorox Company (NYSE:CLX) by 7.0% during the second quarter, Holdings Channel.com reports. The fund owned 1,160,881 shares of the company’s stock after buying an additional 75,514 shares during the period. ProShare Advisors LLC’s holdings in Clorox were worth $139,387,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. American National Bank & Trust increased its holdings in Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after purchasing an additional 89 shares in the last quarter. NewSquare Capital LLC grew its position in shares of Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after buying an additional 193 shares during the period. Hantz Financial Services Inc. bought a new stake in shares of Clorox in the 2nd quarter valued at $31,000. Ransom Advisory Ltd acquired a new position in shares of Clorox during the 1st quarter valued at $35,000. Finally, GW&K Investment Management LLC grew its position in Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after purchasing an additional 208 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of research analyst reports. Rothschild & Co Redburn cut their target price on Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. BNP Paribas Exane cut their price objective on Clorox from $110.00 to $103.00 and set an “underperform” rating on the stock in a research report on Tuesday, November 4th. The Goldman Sachs Group decreased their target price on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research report on Wednesday, October 1st. TD Cowen lowered their target price on Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a research note on Wednesday, October 1st. Finally, Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 28th. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Clorox presently has an average rating of “Reduce” and a consensus target price of $125.69.

Insider Buying and Selling at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.63% of the company’s stock.

Clorox Stock Performance

Shares of CLX opened at $107.37 on Monday. The Clorox Company has a 12-month low of $106.14 and a 12-month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The company has a market cap of $13.10 billion, a PE ratio of 16.47, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52. The stock has a 50-day moving average price of $119.49 and a 200-day moving average price of $124.72.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company’s revenue was down 18.9% on a year-over-year basis. During the same period in the prior year, the company earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd were issued a dividend of $1.24 per share. The ex-dividend date was Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.6%. Clorox’s dividend payout ratio is currently 77.86%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.